Africa may pay as India returns to medical protectionism with vaccine limit (update)

Coronavirus 452 Health Care 279 India 419

The Indian government has reportedly blocked Serum Institute from exporting production of the Oxford University / AstraZeneca SARS-COV-2 vaccine until Indian requirements are met. That marks a return to the medical supply protectionism seen early in the pandemic. The move may hit African markets hardest given they accounted for 42.3% of all Indian vaccine exports in the 12 months to Oct. 31 and given export growth had already reached 63.6% year over year in October. The 30.9% jump in total Indian vaccine exports in October included a 28.4% rise in shipments linked to Serum Institute as w...

Copyright © 2021 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.